Sangamo biosciences presents clinical data demonstrating hiv reservoir reduction in hiv-infected subjects treated with modified immune cells with zinc finger nucleases

SANGAMO BIOSCIENCES PRESENTS CLINICAL DATA DEMONSTRATING HIV RESERVOIR REDUCTION IN HIV-INFECTED SUBJECTS TREATED WITH ZFP THERAPEUTIC®, SB-728-TUnprecedented Immune Reconstitution Drives HIV Viral Reservoir DepletionEncouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 TrialsRichmond, California, May 15, 2013 – Sangamo BioSciences, Inc. (Nasdaq

Source: Nelson Vergel's HIV Blog - May 15, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs